Abstract
Corrigendum to “N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis” [Gene Dis 10 (2023) 554–567]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have